All clinical trials on the European Union Clinical Trials Register (EUCTR) must report their results in the registry within a year of completion. This site tracks who's doing this and who isn't. Learn more »
These trials completed more than 12 months ago and should have reported results.
These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.
These trials have problematic data on the registry. Details why »
Status | Trial ID | Title | Completion date | Category |
---|---|---|---|---|
Reported results | 2010-023021-38 | Switch To RItuXimab in MS A phase 2 open label study of Rituximab in MS patients previously treated with self-injectibles using a target based therapy approach | 2015-04-30 | due-trials |
Ongoing | 2010-024449-65 | Will there be lipid changes during dialysis with Citrasate as dialysate compared to conventional dialysis. | not-yet-due | |
Reported results | 2013-002378-26 | Switch To RItuXimab in MS extension An extension study of STRIX-MS - a phase 2 open label study of Rituximab in MS patients previously treated with self-injectibles using a target based therapy approa... | 2018-04-12 | due-trials |
Ongoing | 2014-001895-72 | VIP-VIZA intensive multimodal cardiovascular intervention sub-study - a phase 2 randomized controlled trial | not-yet-due | |
Reported results | 2018-002385-39 | Infusion of hypertonic solutions: A risk factor for delirium after cardiac surgery? A randomised double blinded controlled trial. | 2020-06-26 | due-trials |